ESMO Virtual Preceptorship on NSCLC 2021

Learning objectives

• To learn about best clinical practice in the management of Non-Small-Cell Lung Cancer (NSCLC) in the adjuvant, locally advanced and metastatic setting
• To understand the importance of pathology and histo-prognostic, molecular factors and liquid biopsies in the management of NSCLC
• To learn about the management of patients after progression, side effects of treatments and the use of targeted agents in NSCLC and obtain some highlights of ongoing clinical research

Download the programme

Accreditation

The programme of this virtual event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

• Pasi A. Jänne, United States
• Tony S. K. Mok, Hong Kong
• Solange Peters, Switzerland